Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perindopril/indapamide and coronary PET scan parameters in hypertension
2004-003955-37Phase 3Completed
- Sponsor
- Servier
- Start
- Apr 2005
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of indapamide + perindopril in essential hypertension, sponsored by Servier. Primary endpoint: Change in coronary PET scan parameters. Started Apr 2005; status: completed.
02
Drugs
indapamide + perindopril
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2004-003955-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003955-37.